Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE BLONDEAU - VANDER CASSYEN from Soignies, company number BE0556942326, closed financial year 2025 with a result of € 156,603 after tax. For that financial year PHARMACIE BLONDEAU - VANDER CASSYEN recorded a gross margin of € 280,470 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 837,356 to € 156,603. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ 1.3 million
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 156,603
▼ 81% vs 2024
Profit after tax over the fiscal year.
€ 130,517
▲ 273% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.3 million.
People and assets in 2025
€ 28,339
▼ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 5.4 million
▲ 245% vs 2024
€ 475,379 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 439
▼ 88% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 56,887
▲ 165% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 96,381 | € 159,757 | € 203,749 | € 280,470 | ▲ 38% |
| Profit after taxes | € 53,156 | € 82,617 | € 837,356 | € 156,603 | ▼ 81% |
| Equity | € 215,268 | € 297,384 | € 1,134,240 | € 1,290,843 | ▲ 14% |
| Total debts | € 1,625,925 | € 2,965,968 | € 3,032,352 | € 7,560,995 | ▲ 149% |
| Cash | € 258,617 | € 39,883 | € 34,952 | € 130,517 | ▲ 273% |
| Retained profit | € 196,668 | € 278,784 | € 1,115,640 | € 1,272,243 | ▲ 14% |
| Dividend | € 500 | € 500 | € 500 | € 0 | ▼ 100% |
| Bank debt | € 1,160,146 | € 2,505,606 | € 1,560,409 | € 5,376,936 | ▲ 245% |
| Balance sheet total | € 1,841,193 | € 3,263,353 | € 4,166,592 | € 8,851,837 | ▲ 112% |
Key figures of PHARMACIE BLONDEAU - VANDER CASSYEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE BLONDEAU - VANDER CASSYEN?
What happened at PHARMACIE BLONDEAU - VANDER CASSYEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 156,603 (▼ 81% vs 2024). filed late Source: NBB ↗
- New establishment in Soignies. KBO
- VIRGINIE VANDER CASSYEN became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 53,156 profit in 2022 to € 156,603 profit in 2025.
Paid € 103,776 in corporate taxes since 2022.
Best year ever: 2024, with € 837,356 profit.
Paid out € 1,500 in dividends to the owners in total.
A new publication or filing at PHARMACIE BLONDEAU - VANDER CASSYEN? We notify you, reason included.
Follow PHARMACIE BLONDEAU - VANDER CASSYENDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE BLONDEAU - VANDER CASSYEN is VIRGINIE VANDER CASSYEN. It owns 100% of PHALADEL SA, 100% of PHARMAVIE THIEU, 100% of PHARMACIE PHARMAVIE LE ROEULX, 100% of PHARMAVIE GILLY, 100% of PHARMACIE PHARMAVIE HARCHIES and 100% of PHARMACIE GLORIEUX itself.
Directors
According to the 2025 annual accounts
VIRGINIE VANDER CASSYEN
Administrator-manager
since 2014
Establishments
Establishment units
Physical locations of this company
Rue de Sirieu 173 box C
7061 Soignies
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0556.942.326
- VAT number
- BE 0556.942.326
- Registered office
- Rue de Sirieu 173 bus C, 7061 Soignies
- Names & denominations
- PHARMACIE BLONDEAU - VANDER CASSYEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 July 2014
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten